Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11128633rdf:typepubmed:Citationlld:pubmed
pubmed-article:11128633lifeskim:mentionsumls-concept:C0242643lld:lifeskim
pubmed-article:11128633lifeskim:mentionsumls-concept:C0242640lld:lifeskim
pubmed-article:11128633lifeskim:mentionsumls-concept:C0020924lld:lifeskim
pubmed-article:11128633lifeskim:mentionsumls-concept:C1709060lld:lifeskim
pubmed-article:11128633lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:11128633lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:11128633lifeskim:mentionsumls-concept:C1518413lld:lifeskim
pubmed-article:11128633lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:11128633pubmed:issue23lld:pubmed
pubmed-article:11128633pubmed:dateCreated2000-12-20lld:pubmed
pubmed-article:11128633pubmed:abstractTextSolution-phase combinatorial chemistry was applied to the optimization and development of clinical candidate OC144-093 (22), a novel and nontoxic modulator of P-glycoprotein mediated multidrug resistance.lld:pubmed
pubmed-article:11128633pubmed:languageenglld:pubmed
pubmed-article:11128633pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11128633pubmed:citationSubsetIMlld:pubmed
pubmed-article:11128633pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11128633pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11128633pubmed:statusMEDLINElld:pubmed
pubmed-article:11128633pubmed:monthDeclld:pubmed
pubmed-article:11128633pubmed:issn0960-894Xlld:pubmed
pubmed-article:11128633pubmed:authorpubmed-author:DixonRRlld:pubmed
pubmed-article:11128633pubmed:authorpubmed-author:ZhangCClld:pubmed
pubmed-article:11128633pubmed:authorpubmed-author:MoranE JEJlld:pubmed
pubmed-article:11128633pubmed:authorpubmed-author:KraneSSlld:pubmed
pubmed-article:11128633pubmed:authorpubmed-author:RodarteJ CJClld:pubmed
pubmed-article:11128633pubmed:authorpubmed-author:BenbatoulK...lld:pubmed
pubmed-article:11128633pubmed:authorpubmed-author:SarsharSSlld:pubmed
pubmed-article:11128633pubmed:authorpubmed-author:MjalliA MAMlld:pubmed
pubmed-article:11128633pubmed:issnTypePrintlld:pubmed
pubmed-article:11128633pubmed:day4lld:pubmed
pubmed-article:11128633pubmed:volume10lld:pubmed
pubmed-article:11128633pubmed:ownerNLMlld:pubmed
pubmed-article:11128633pubmed:authorsCompleteYlld:pubmed
pubmed-article:11128633pubmed:pagination2603-5lld:pubmed
pubmed-article:11128633pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11128633pubmed:meshHeadingpubmed-meshheading:11128633...lld:pubmed
pubmed-article:11128633pubmed:meshHeadingpubmed-meshheading:11128633...lld:pubmed
pubmed-article:11128633pubmed:meshHeadingpubmed-meshheading:11128633...lld:pubmed
pubmed-article:11128633pubmed:meshHeadingpubmed-meshheading:11128633...lld:pubmed
pubmed-article:11128633pubmed:meshHeadingpubmed-meshheading:11128633...lld:pubmed
pubmed-article:11128633pubmed:meshHeadingpubmed-meshheading:11128633...lld:pubmed
pubmed-article:11128633pubmed:meshHeadingpubmed-meshheading:11128633...lld:pubmed
pubmed-article:11128633pubmed:meshHeadingpubmed-meshheading:11128633...lld:pubmed
pubmed-article:11128633pubmed:meshHeadingpubmed-meshheading:11128633...lld:pubmed
pubmed-article:11128633pubmed:year2000lld:pubmed
pubmed-article:11128633pubmed:articleTitle2,4,5-Trisubstituted imidazoles: novel nontoxic modulators of P-glycoprotein mediated multidrug resistance. Part 2.lld:pubmed
pubmed-article:11128633pubmed:affiliationOntogen Corporation, Carlsbad, CA 92009, USA.lld:pubmed
pubmed-article:11128633pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:11128633lld:chembl